0 Trusted Subscribers
0 Tenders Listed
Daily Updates
Procurement and Supply of Medicines Framework Agreement
Expired Tender
Closing Date:
2026-07-24
2026-07-24
Tender Overview
- Category
- Pharmaceuticals
- Sector
- Goods
- Tender Type
- Goods
- Source Name
- Balochistan PPRA
Location & Dates
- City
- Quetta
- Province
- Balochistan
- Country
- Pakistan
- Publish Date
- 2026-07-27
- Closing Date
- 2026-07-24
- Created At
- 2026-07-27 23:18:59
Contact & Websites
Actions
Back to All Tenders
Looking for more tenders like this? View all active Pharmaceuticals tenders.
Related Tenders
Supply of Medicines to Directorate of Procurement (Navy) Islamabad
Close: 2026-12-18 Islamabad, Islamabad Capital Territory
Procurement of Surgical, Disposables, Implants, Nuclear Medicines, Cardiology / Cath Lab and...
Close: 2026-12-17 Karachi, Sindh
Framework Contracts for General Store Items, Stationary Items, Bulk Medicine, and Surgical...
Close: 2026-12-05 Gujrat, Punjab
Hiring of Pharmacy for Local Purchase of Medicines in Multiple Khyber Pakhtunkhwa...
Close: 2026-12-07 Peshawar, Khyber Pakhtunkhwa
Procurement of Fodder for Animals and Supply of Medicines at Wildlife Peshawar...
Close: 2026-12-09 Peshawar, Khyber Pakhtunkhwa
Supply of Veterinary Medicines for Horse Riding School PAF Academy Asghar Khan
Close: 2026-11-30 Risapur
Tender Description
The Balochistan Essential Services and Supplies Institute (BESSI) in Quetta is procuring medicines under a framework agreement to ensure continuous supply for the province. This procurement is critical for maintaining essential health services and supporting public health infrastructure in Balochistan.
Items being procured:
- Medicines (specific list not provided in the notice)
The procurement involves the supply of various medicines as per the framework agreement. The technical scope includes ensuring quality and timely delivery of medicines to designated health facilities across Balochistan. Bidders must comply with all regulatory standards and ensure medicines meet required specifications.
Eligibility criteria typically include valid PEC registration if applicable, FBR registration, and relevant experience in pharmaceutical supply. Bidders should carefully review the bidding documents for detailed requirements and ensure compliance with all terms.
The original advertisement was published on 17 July 2026, with the closing date for submissions on 24 July 2026. Bidders are advised to submit their bids before the deadline to avoid disqualification. The corrigendum clarifies that bidders are no longer required to submit samples during the technical evaluation stage, simplifying the submission process.
A practical tip for bidders is to thoroughly check the updated bidding documents and ensure all required documents are complete and properly signed. Missing or incomplete documentation is a common cause of bid rejection. Staying updated with corrigenda like this one is essential to avoid unnecessary submissions such as samples, saving time and resources.
